Literature DB >> 22933566

Apixaban in renal insufficiency: successful navigation between the Scylla and Charybdis.

Jan Steffel, Gerhard Hindricks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22933566     DOI： 10.1093/eurheartj/ehs267

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  3 in total

Review 1.  Apixaban: a review of its use for reducing the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-06       Impact factor: 9.546

Review 2.  Novel Anticoagulants in Atrial Fibrillation: Monitoring, Reversal and Perioperative Management.

Authors:  Fadi Shamoun; Hiba Obeid; Harish Ramakrishna
Journal:  Biomed Res Int       Date:  2015-07-02       Impact factor: 3.411

Review 3.  Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban.

Authors:  Kenechukwu Mezue; Chukwudi Obiagwu; Jinu John; Abhishek Sharma; Felix Yang; Jacob Shani
Journal:  Curr Cardiol Rev       Date:  2017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.